Most Read Articles
5 days ago
Higher activity of plasma xanthine oxidase appears to be linked to insulin resistance and liver dysfunction among type 2 diabetes mellitus (T2DM) patients with metabolic syndrome (MetS), according to a recent Japan study.
5 days ago
Use of quetiapine among critically ill patients rarely leads to corrected QT (QTc) interval prolongation, reports a new study.
6 days ago
New drug applications approved by US FDA as of 1 - 15 June 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Pearl Toh, 5 days ago
Drinking more water did not significantly slow down the decline in kidney function of patients with stage 3 chronic kidney disease (CKD) at 1 year compared with patients who maintained their daily water intake, the CKD WIT* randomized study suggests.

Persistent pulmonary hypertension of newborn tied to higher mortality, sepsis

28 Apr 2018
Rare diseases, under the Singapore law, refer to the illnesses that are “life-threatening and severely debilitating” – and are often not easy to be spotted.

Persistent pulmonary hypertension of the newborn (PPHN) is a common phenomenon in infants with moderate or severe hypoxic ischaemic encephalopathy (HIE), a recent study has shown. Moreover, PPHN is linked to lung disease, sepsis and increased mortality.

Drawing from two randomized trials of therapeutic hypothermia, researchers analysed the information of 303 infants with HIE, of whom 22 percent (n=67; mean gestational age at birth 38.7±1.8 weeks; 57 percent male) had PPHN. Maternal hypertension (6 percent vs 16 percent) and uterine rupture (3 percent vs 13 percent; p<0.05 for both) were all significantly less common in the PPHN group.

Meconium aspiration syndrome (39 percent vs 7 percent), pulmonary haemorrhage (12 percent vs 3 percent), sepsis (12 percent vs 3 percent), cardiac dysfunction by echo (27 percent vs 5 percent), cardiomegaly (15 percent vs 1 percent) and systemic hypotension (65 percent vs 28 percent) were all significantly more common in infants with vs without PPHN (p<0.05 for all).

Patients with PPHN also had a significantly longer duration of hospital stay (26.0±21.3 vs 16.4±14.3 days; p<0.05).

In-hospital mortality was likewise significantly higher in those with PPHN (27 percent vs 16 percent; p<0.05), though the significance was attenuated upon adjusting for baseline HIE severity (adjusted odds ratio [OR], 1.52; 95 percent CI, 0.76–3.02; p=0.24).

Notably, in those with moderate HIE, the PPHN vs no-PPHN group had significantly higher mortality rates (18 percent vs 8 percent; adjusted OR, 2.73; 1.01–7.39; p=0.048).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Higher activity of plasma xanthine oxidase appears to be linked to insulin resistance and liver dysfunction among type 2 diabetes mellitus (T2DM) patients with metabolic syndrome (MetS), according to a recent Japan study.
5 days ago
Use of quetiapine among critically ill patients rarely leads to corrected QT (QTc) interval prolongation, reports a new study.
6 days ago
New drug applications approved by US FDA as of 1 - 15 June 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Pearl Toh, 5 days ago
Drinking more water did not significantly slow down the decline in kidney function of patients with stage 3 chronic kidney disease (CKD) at 1 year compared with patients who maintained their daily water intake, the CKD WIT* randomized study suggests.